Center for Epidemiology and Evidence Based Practice, Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
Ministry of Health, 62590 Putrajaya, Malaysia.
Trans R Soc Trop Med Hyg. 2021 Jul 1;115(7):764-771. doi: 10.1093/trstmh/trab021.
Dengue, an acute infectious disease caused by a flavivirus, is a threat to global health. There is sparse evidence exploring obesity and the development of more severe dengue cases in adults. With increasing prevalence of obesity in areas with a high risk of dengue infection, obesity may increase the burden and mortality related to dengue infection. Our study aimed to determine the association between obesity and the development of more severe dengue infection in primary healthcare settings and whether these associations were modified by dengue fever phase.
A cohort study was conducted among laboratory-confirmed dengue patients aged >18 y in the central region of Peninsular Malaysia from May 2016 to November 2017. We collected demographic, clinical history, physical examination and laboratory examination information using a standardized form. Dengue severity (DS) was defined as either dengue with warning signs or severe dengue. Participants underwent daily follow-up, during which we recorded their vital signs, warning signs and full blood count results. Incidence of DS was modeled using mixed-effects logistic regression. Changes in platelet count and hematocrit were modeled using mixed-effects linear regression. The final multivariable models were adjusted for age, gender, ethnicity and previous dengue infection.
A total of 173 patients were enrolled and followed up. The mean body mass index (BMI) was 37.4±13.75 kg/m2. The majority of patients were Malay (65.9%), followed by Chinese (17.3%), Indian (12.7%) and other ethnic groups (4.1%). A total of 90 patients (52.0%) were male while 36 patients (20.8%) had a previous history of dengue infection. BMI was significantly associated with DS (adjusted OR=1.17; 95% CI 1.04 to 1.34) and hematocrit (%) (aβ=0.09; 95% CI 0.01 to 0.16), but not with platelet count (x103/µL) (aβ=-0.01; 95% CI -0.84 to 0.81). In the dose response analysis, we found that as BMI increases, the odds of DS, hematocrit levels and platelet levels increase during the first phase of dengue fever.
Higher BMI and higher hematocrit levels were associated with higher odds of DS. Among those with high BMI, the development of DS was observed during phase one of dengue fever instead of during phase two. These novel results could be used by clinicians to help them risk-stratify dengue patients for closer monitoring and subsequent prevention of severe dengue complications.
登革热是由黄病毒引起的急性传染病,对全球健康构成威胁。目前关于肥胖与成年人更严重登革热病例发展之间的关系的证据很少。在登革热感染高危地区,肥胖的患病率不断增加,肥胖可能会增加与登革热感染相关的负担和死亡率。本研究旨在确定肥胖与基层医疗机构中更严重登革热感染发展之间的关联,以及这些关联是否因登革热发热期而改变。
这是一项在马来西亚半岛中部地区进行的队列研究,纳入了 2016 年 5 月至 2017 年 11 月期间年龄大于 18 岁的实验室确诊登革热患者。我们使用标准化表格收集了人口统计学、临床病史、体格检查和实验室检查信息。登革热严重程度(DS)定义为有警告症状的登革热或严重登革热。对参与者进行了每日随访,在此期间记录了他们的生命体征、警告症状和全血细胞计数结果。使用混合效应逻辑回归模型来计算 DS 的发生率。使用混合效应线性回归模型来计算血小板计数和血细胞比容的变化。最终的多变量模型调整了年龄、性别、种族和既往登革热感染。
共纳入并随访了 173 名患者。平均体重指数(BMI)为 37.4±13.75kg/m2。大多数患者为马来人(65.9%),其次是华人(17.3%)、印度人(12.7%)和其他种族群体(4.1%)。90 名患者(52.0%)为男性,36 名患者(20.8%)有既往登革热感染史。BMI 与 DS(调整后的 OR=1.17;95%CI 1.04 至 1.34)和血细胞比容(%)(aβ=0.09;95%CI 0.01 至 0.16)显著相关,但与血小板计数(x103/µL)(aβ=-0.01;95%CI -0.84 至 0.81)无关。在剂量反应分析中,我们发现随着 BMI 的增加,登革热发热期的 DS、血细胞比容和血小板水平的发生几率增加。
较高的 BMI 和较高的血细胞比容水平与 DS 的发生几率增加相关。在 BMI 较高的患者中,DS 的发生发生在登革热发热期的第一阶段,而不是第二阶段。这些新的结果可被临床医生用于帮助他们对登革热患者进行风险分层,以便进行更密切的监测,并随后预防严重登革热并发症。